EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biological Activities of Bismuth Compounds: An Overview of the New Findings and the Old Challenges Not Yet Overcome

Jânia Dos Santos Rosário, Fábio Henrique Moreira, Lara Hewilin Fernandes Rosa, Wendell Guerra, Priscila Pereira Silva-Caldeira iD

Molecules · 07.08.2023 · 28 (15) · 5921

DOI: 10.3390/molecules28155921 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 07.08.2023. Verfasst von Jânia Dos Santos Rosário und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Centro Federal de Educação Tecnológica de Minas Gerais, Belo Horizonte 30421-169, MG, Brazil. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, FAPEMIG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bismuth-based drugs have been used primarily to treat ulcers caused by Helicobacter pylori and other gastrointestinal ailments. Combined with antibiotics, these drugs also possess synergistic activity, making them ideal for multiple therapy regimens and overcoming bacterial resistance. Compounds based on bismuth have a low cost, are safe for human use, and some of them are also effective against tumoral cells, leishmaniasis, fungi, and viruses. However, these compounds have limited bioavailability in physiological environments. As a result, there is a growing interest in developing new bismuth compounds and approaches to overcome this challenge. Considering the beneficial properties of bismuth and the importance of discovering new drugs, this review focused on the last decade’s updates involving bismuth compounds, especially those with potent activity and low toxicity, desirable characteristics for developing new drugs. In addition, bismuth-based compounds with dual activity were also highlighted, as well as their modes of action and structure–activity relationship, among other relevant discoveries. In this way, we hope this review provides a fertile ground for rationalizing new bismuth-based drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriHelicobacter InfectionsHumansBismuthAnti-Bacterial AgentsDrug Therapy, Combination

Stichwörter der Autor:innen

Helicobacter pyloriantimicrobial activityantiparasitic activityantiviral activitybacterial resistancebismuthcancer

Substanzen

BismuthAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Chemistry, Centro Federal de Educação Tecnológica de Minas Gerais, Belo Horizonte 30421-169, MG, Brazil.
  • Institute of Chemistry, Universidade Federal de Uberlândia, Campus Santa Mônica, Uberlândia 38400-142, MG, Brazil.

ORCID-Profile: Priscila Pereira Silva-Caldeira

Förderung

  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • FAPEMIG

Zitieren

APA

Rosário, J. D. S., Moreira, F. H., Rosa, L. H. F., Guerra, W., & Silva-Caldeira, P. P. (2023). Biological Activities of Bismuth Compounds: An Overview of the New Findings and the Old Challenges Not Yet Overcome. Molecules, 28(15), 5921. https://doi.org/10.3390/molecules28155921

Vancouver

Rosário JDS, Moreira FH, Rosa LHF, Guerra W, Silva-Caldeira PP. Biological Activities of Bismuth Compounds: An Overview of the New Findings and the Old Challenges Not Yet Overcome. Molecules. 2023;28(15):5921. doi:10.3390/molecules28155921

BibTeX
@article{Rosrio2023,
  author = {Rosário, Jânia Dos Santos and Moreira, Fábio Henrique and Rosa, Lara Hewilin Fernandes and Guerra, Wendell and Silva-Caldeira, Priscila Pereira},
  title = {Biological Activities of Bismuth Compounds: An Overview of the New Findings and the Old Challenges Not Yet Overcome},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {15},
  pages = {5921},
  doi = {10.3390/molecules28155921}
}
Kostenlos starten →